The current head, John Crowley, a biotech executive and rare disease advocate, took over in March. GSK has spent slightly ...
Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
GlaxoSmithKline's head of oncology Axel Hoos has resigned from the company, and will take up a new role as chief executive of US biotech Scorpion Therapeutics. Hoos is leaving GSK after nine ...
Prior to JWT/WT, North, Chauhan was the head of the agency's Sri Lanka operations and JWT (South). Chauhan has also worked at ...
GSK’s departure comes as the industry anticipates the incoming Trump administration and as it continues to grapple with the threat of the BIOSECURE Act and losses of legal challenges to the IRA’s drug ...
The British pharma’s experience during the third quarter mirrored that of rival Pfizer, which also reported lower sales of ...
the North office was responsible for numerous global and Indian brands like, PepsiCo, Nestle, GSK, Hero MotoCorp, Honda ...
The Q3 presentation was sent to our distribution list by e-mail and you can also find it on gsk.com. Please turn to ... from the PASO DOBLE study, a large head-to-head randomized clinical trial ...
On Monday, GSK plc (NYSE:GSK) released headline results from the phase 3 trials ANCHOR-1 and ANCHOR-2, which assessed the efficacy and safety of depemokimab versus placebo in adults with chronic ...
Diabetes Singapore and GSK aim to enhance awareness and improve lives affected by diabetes through educational talks and activities on World Diabetes Day; 1 in 3 people will get s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback